Los Angeles Capital Management
IPXL

Los Angeles Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Los Angeles Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,245
Closed -$130K – 1288
2017
Q1 		$130K Sell
10,245
-590
-5% -$7.13K ﹤0.01% 1119
2016
Q4 		$144K Buy
10,835
+350
+3% +$5.98K ﹤0.01% 1132
2016
Q3 		$248K Buy
+10,485
New +$282K ﹤0.01% 1113
2016
Q1 		– Sell
-5,652
Closed -$242K – 1225
2015
Q4 		$242K Sell
5,652
-760
-12% -$30.4K ﹤0.01% 1027
2015
Q3 		$226K Sell
6,412
-3,688
-37% -$166K ﹤0.01% 1080
2015
Q2 		$464K Sell
10,100
-6,630
-40% -$315K ﹤0.01% 953
2015
Q1 		$784K Buy
16,730
+60
+0.4% +$2.39K 0.01% 804
2014
Q4 		$528K Sell
16,670
-625
-4% -$18.3K ﹤0.01% 822
2014
Q3 		$410K Sell
17,295
-340
-2% -$8.71K 0.01% 829
2014
Q2 		$529K Sell
17,635
-7,995
-31% -$216K 0.01% 859
2014
Q1 		$677K Buy
25,630
+13,480
+111% +$337K 0.01% 782
2013
Q4 		$305K Hold
12,150
– – ﹤0.01% 1072
2013
Q3 		$249K Sell
12,150
-2,530
-17% -$52.2K ﹤0.01% 1155
2013
Q2 		$293K Buy
+14,680
New +$261K ﹤0.01% 1075

Other funds holding IPXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Los Angeles Capital Management's IPXL Position: Q2 2017 in Review

Los Angeles Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 10,245 shares — an estimated $130K sold.

Los Angeles Capital Management first reported a position in IPXL in Q2 2013 and held it in 14 quarters. The position peaked at $784K in Q1 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • Los Angeles Capital Management reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • Los Angeles Capital Management sold 10,245 Impax Laboratories, Inc. shares in Q2 2017, an estimated $130K.
  • Los Angeles Capital Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 14 quarters.
  • Los Angeles Capital Management's Impax Laboratories, Inc. position peaked at $784K in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Los Angeles Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.